T1	Drug 0 10	Amiodarone
T2	Drug 12 42	P-glycoprotein (P-gp) inducers
T3	Drug 50 58	rifampin
T4	Drug 60 75	St. John's wort
*	OR T3 T4
T5	Scope 50 75	rifampin, St. John's wort
R1	Subsumes Arg1:T2 Arg2:T5	
T6	Procedure 78 90	Liver biopsy
T7	Measurement 111 121	mHAI stage
T8	Value 122 133	4 or higher
R2	Has_value Arg1:T7 Arg2:T8	
R3	AND Arg1:T6 Arg2:T7	
T9	Temporal 94 102	any time
R4	Has_temporal Arg1:T6 Arg2:T9	
T10	Procedure 147 156	FibroScan
T11	Temporal 157 173	within 12 months
R5	Has_temporal Arg1:T10 Arg2:T11	
T12	Measurement 188 203	liver stiffness
T13	Value 207 223	=9.5 kilo Pascal
R6	Has_value Arg1:T12 Arg2:T13	
R7	AND Arg1:T10 Arg2:T12	
T14	Measurement 228 262	AST to platelet ratio index (APRI)
T15	Value 263 267	=2.0
R8	Has_value Arg1:T14 Arg2:T15	
T16	Measurement 272 290	Fibrosis-4 (FIB-4)
T17	Value 291 296	=3.25
R9	Has_value Arg1:T16 Arg2:T17	
*	OR T14 T16
T18	Non-representable 298 393	NOTE: If APRI and FIB-4 are discordant one of the other forms of fibrosis staging must be used.
T19	Condition 401 408	allergy
T20	Condition 409 420	sensitivity
*	OR T20 T19 T21
T21	Condition 428 444	hypersensitivity
T22	Drug 448 473	components of study drugs
T23	Scope 401 444	allergy/sensitivity or any hypersensitivity
R10	AND Arg1:T23 Arg2:T22	
T24	Condition 497 512	Hemochromatosis
T25	Condition 514 544	Alpha-1 antitrypsin deficiency
T26	Condition 546 562	Wilson's disease
T27	Condition 564 584	Autoimmune hepatitis
T28	Condition 586 609	Alcoholic liver disease
T29	Condition 611 637	Drug-related liver disease
T30	Condition 673 679	stroke
T31	Condition 681 692	head injury
T32	Condition 697 730	developmental learning disability
*	OR T31 T32 T30
T33	Condition 646 671	NC confounding conditions
T34	Scope 673 730	stroke, head injury, or developmental learning disability
R11	Subsumes Arg1:T33 Arg2:T34	
T35	Drug 749 772	anti-inflammatory drugs
T36	Drug 808 828	pegylated interferon
T37	Drug 830 837	PEG-IFN
R12	Subsumes Arg1:T36 Arg2:T37	
T38	Procedure 793 802	treatment
T39	Temporal 786 792	recent
T40	Temporal 775 782	Current
*	OR T39 T40
R13	AND Arg1:T38 Arg2:T36	
T41	Scope 775 792	Current or recent
R14	Has_scope Arg1:T38 Arg2:T41	
T42	Condition 847 874	active inflammatory process
T43	Qualifier 841 846	Other
R15	Has_qualifier Arg1:T42 Arg2:T43	
T44	Condition 876 891	major infection
T45	Condition 893 903	malignancy
T46	Condition 905 925	rheumatoid arthritis
T47	Condition 926 945	autoimmune disorder
*	OR T47 T46 T45 T44
T48	Scope 876 945	major infection, malignancy, rheumatoid arthritis/autoimmune disorder
R16	Subsumes Arg1:T42 Arg2:T48	
T49	Temporal 947 971	within the prior 28 days
R17	Has_temporal Arg1:T42 Arg2:T49	
T50	Procedure 995 1027	magnetic resonance imaging (MRI)
T51	Condition 974 991	Contraindications
R18	AND Arg1:T51 Arg2:T50	
T52	Condition 1030 1048	Bleeding diathesis
T53	Condition 1050 1066	thrombocytopenia
T54	Drug 1078 1092	anticoagulants
T55	Condition 1104 1118	contraindicate
T56	Procedure 1119 1134	lumbar puncture
R19	AND Arg1:T55 Arg2:T56	
R20	AND Arg1:T54 Arg2:T55	
*	OR T53 T52 T54
T57	Temporal 1153 1159	active
T58	Qualifier 1137 1149	Uncontrolled
T59	Condition 1160 1170	depression
*	OR T57 T58
T60	Scope 1137 1159	Uncontrolled or active
T61	Condition 1180 1200	psychiatric disorder
T62	Qualifier 1174 1179	other
R21	Has_qualifier Arg1:T61 Arg2:T62	
*	OR T59 T61
T63	Scope 1160 1200	depression or other psychiatric disorder
R22	Has_scope Arg1:T63 Arg2:T60	
T64	Condition 1351 1376	alcohol use or dependence
T65	Condition 1343 1347;1359 1376	drug use or dependence
*	OR T64 T65
T66	Temporal 1336 1342	Active
T67	Scope 1343 1376	drug or alcohol use or dependence
R23	Has_temporal Arg1:T67 Arg2:T66	
T68	Temporal 1501 1506	acute
T69	Temporal 1491 1497	active
T70	Condition 1507 1545	AIDS-defining opportunistic infections
T71	Temporal 1546 1582	within 12 weeks prior to study entry
*	OR T68 T69
T72	Scope 1491 1506	active or acute
R24	Has_temporal Arg1:T70 Arg2:T71	
R25	Has_scope Arg1:T70 Arg2:T72	
